MedTrace Logo

Hyaluronic Acid for the Treatment of Damaged Nipples in Breastfeeding Women

NCT05591651 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2024-07-31

No results posted yet for this study

Summary

Previous studies have shown that application of hyaluronic acid preparations to wounds of the skin and mucosa have a beneficial effect.

There is a lack of studies showing the effect of applying hyaluronic acid preparations to treat damaged nipple skin in breastfeeding mothers.

This study aims to determine the effect of applying a hyaluronic acid preparation to damaged nipple skin in breastfeeding women.

Conditions

  • Cracked Nipple
  • Breastfeeding
  • Healing Wound

Interventions

DRUG

Treatment of damaged nipple skin: Preparation with hyaluronic acid

The active preparation will be applied for five days, locally on the damaged nipple skin after every second breastfeeding session, and at least four times in 24 hours, alternating it with breast milk.

DRUG

Treatment of damaged nipple skin: Neutral preparation without hyaluronic acid

The neutral preparation, containing only white vaseline, will be applied for five days, locally on the damaged nipple skin after every second breastfeeding session, and at least four times in 24 hours, alternating it with breast milk.

Sponsors & Collaborators

  • Specijalisticka Pedijatrijska Ordinacija prim.mr.sc. Maja Stimac, Specijalist Pedijatrije Sspecijalnosti Neonatologije

    lead OTHER

Principal Investigators

  • Maja Štimac, MD; Mr.sc. · Specijalistička pedijatrijska ordinacija prim.mr.sc.Maja Štimac

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-09
Primary Completion
2025-12-31
Completion
2026-02-28

Countries

  • Croatia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05591651 on ClinicalTrials.gov